FIG. 5.

IVGF studies revealed protection of IL-6 type II RE, MREs, GRE1, and a unique γ-IRE site of the MT-I promoter in the lung of infected C57BL/6 mice. This experiment was done following the same protocol as described for the liver in Fig. 4 with the exception that nuclei and naked DNA from the lung were used. (A) Footprinting with 5′ STAT3 primers. (B) Footprinting with 3′ and 5′ mMT-I primers. (C) Footprinting with 3′ GRE primers.